NDC 46066-550 - Lincomycin S 50
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 46066-550
- Package NDCs from labels
- 46066-550-01
- Manufacturer
- Aspen Veterinary Resources | Bimeda Inc. | Shandong Qilu Kingphar Pharmaceutical Co., Ltd.
- Effective date
- 2023-09-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lincomycin S 50 | Aspen Veterinary Resources | Bimeda Inc. | Shandong Qilu Kingphar Pharmaceutical Co., Ltd. | 2023-09-26 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LINCOMYCIN HYDROCHLORIDE | ACTIVE INGREDIENT | M6T05Z2B68 | LINCOMYCIN S 50 (LINCOMYCIN SPECTINOMYCIN) POWDER [ASPEN VETERINARY RESOURCES] | 7 | |
| SPECTINOMYCIN HYDROCHLORIDE | ACTIVE INGREDIENT | HWT06H303Z | LINCOMYCIN S 50 (LINCOMYCIN SPECTINOMYCIN) POWDER [ASPEN VETERINARY RESOURCES] | 7 | |
| LINCOMYCIN | ACTIVE MOIETY | BOD072YW0F | LINCOMYCIN S 50 (LINCOMYCIN SPECTINOMYCIN) POWDER [ASPEN VETERINARY RESOURCES] | 7 | |
| SPECTINOMYCIN | ACTIVE MOIETY | 93AKI1U6QF | LINCOMYCIN S 50 (LINCOMYCIN SPECTINOMYCIN) POWDER [ASPEN VETERINARY RESOURCES] | 7 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lincomycin | LINCOMYCIN | Micro Labs Limited | 20c0e8af-a78f-47f8-ace4-06b80def7003 | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
| LINCOMYCIN | LINCOMYCIN HYDROCHLORIDE | Henry Schein, Inc. | a7692968-7ac8-48ab-89a4-27c7803e31f4 | 2025-10-31 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
| Lincocin | LINCOMYCIN HYDROCHLORIDE | Pharmacia & Upjohn Company LLC | c01906fa-2c73-4c13-9765-2fd06628d263 | 2025-03-10 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 23f9608c-3126-35db-e063-6294a90af054 | 2024-10-08 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
| Lincomycin | LINCOMYCIN | Armas Pharmaceuticals Inc. | ebabccf4-f082-4fc0-9223-f4826dc89b13 | 2023-05-18 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
| Lincomycin | LINCOMYCIN | Armas Pharmaceuticals Inc. | fd2838b7-f8c9-4049-a306-ea620a9c0fe2 | 2023-05-08 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | Sagent Pharmaceuticals | 75e149cc-b668-427e-bae7-a0d215e4fb7a | 2023-03-20 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
| Lincomycin | LINCOMYCIN HYDROCHLORIDE | XGen Pharmaceuticals DJB, Inc. | 61f4851d-d919-400d-912a-05eb9dca11d4 | 2022-10-14 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
| lincomycin hydrochloride | LINCOMYCIN HYDROCHLORIDE | Gland Pharma Limited | c2b5be20-cc6f-4221-9d3e-3f8b5886cd05 | 2022-09-28 | Boxed warning, Warnings, Adverse reactions | M6T05Z2B68 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.